University of Michigan Rogel Cancer Center: Carcinoma trials

The registry lists 19 Carcinoma studies with University of Michigan Rogel Cancer Center as lead sponsor. 0 are open to participants now and 11 have results posted.

Early Phase 1 2Phase 1 4Phase 2 11Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line TherapyTerminatedNCT04497038Phase 1/2Results posted
• Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT03562507Phase 2Results posted
• Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial CarcinomaTerminatedNCT03287050Phase 2Results posted
• Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT03194373Phase 2Results posted
• Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell CarcinomaCompletedNCT02729194Early Phase 1Results posted
• A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular CarcinomaCompletedNCT02460835Not applicableResults posted
• VISmodegib for ORbital and Periocular Basal Cell CarcinomaCompletedNCT02436408Phase 4Results posted
• Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell CarcinomaTerminatedNCT02138578Not applicableResults posted
• A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and NeckTerminatedNCT01285635Phase 2Results posted
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic CarcinomaTerminatedNCT00843830Phase 1Results posted
• Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal CarcinomaCompletedNCT00176800Phase 2Results posted
• Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based ChemotherapyTerminatedNCT03208712Early Phase 1
• Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular CarcinomaWithdrawnNCT03168152Not applicable
• Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)WithdrawnNCT02997956Phase 1/2
• A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell CarcinomaWithdrawnNCT02649530Phase 2
• Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.TerminatedNCT00565227Phase 1
• Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma EsophagusTerminatedNCT00239200Phase 2
• Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteTerminatedNCT00148135Phase 2